세계의 체성분 분석기 시장 보고서 : 제품, 최종 사용자, 지역별(2024-2032년)

The global body composition analyzers market size reached US$ 775.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,471.3 Million by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032.

A body composition analyzer (BCA) is an equipment that is used to measure weight, body fat, water percentage, BMR, DCI, metabolic age, bone mass, muscle mass, and physique and visceral fat rating. It defines weight more accurately than body mass index (BMI) and is also capable of projecting cumulative variations in the body for a certain amount of time. Nowadays, a wide range of BCA models, including Ironman, FitScan and Innerscan, are available in the market that provide relevant measurement values and data to medical professionals, which helps in tracking patient progress, and the diagnostics and screening of obesity and associated comorbidities.

The primary factor bolstering the growth of the global BCA market is the rapid growth of the obese population due to sedentary lifestyles and unhealthy dietary patterns. With the rising obesity rates and other metabolic disorders, there has been an increase in awareness among individuals about the importance of health and wellness. This has encouraged them to join health clubs and fitness centers to reduce weight. As these centers utilize BCA to test the body composition of individuals regularly, it is providing a positive impact on the industry growth. Moreover, market players have also developed Bio-electrical Impedance Analysis (BIA), which is a non-invasive tool used by medical practitioners to measure the percentage of body fat. They have also developed ANT+ and Bluetooth wireless body composition analyzers with dual LCD units. Apart from this, due to the ongoing spread of coronavirus disease (COVID-19) across the globe, governments of various nations are making investments in the development of healthcare infrastructure, which is further creating a huge demand for medical devices.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global body composition analyzers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and end user.

Breakup by Product:

Bioimpedance Analyzer

Skinfold Calipers

Hydrostatic Weighing Equipment

Air Displacement Plethysmography

Dual Energy X-Ray Absorptiometry

Others

Breakup by End User:

Hospitals

Fitness Clubs and Wellness Centers

Academic and Research Centers

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Bodystat Ltd., COSMED Srl, GE Healthcare, Hologic Inc., Inbody Co. Ltd., Omron Corporation, RJL Systems Inc., Seca GmbH & Co. Kg., SELVAS Healthcare and Tanita Corporation.

Key Questions Answered in This Report:

• How has the global body composition analyzers market performed so far and how will it perform in the coming years?
• What are the key regional markets?
• What has been the impact of COVID-19 on the global body composition analyzers market?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global body composition analyzers market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Body Composition Analyzers Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Bioimpedance Analyzer
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Skinfold Calipers
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Hydrostatic Weighing Equipment
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Air Displacement Plethysmography
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Dual Energy X-Ray Absorptiometry
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Others
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by End User

• 7.1 Hospitals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Fitness Clubs and Wellness Centers
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Academic and Research Centers
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Bodystat Ltd.
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 COSMED Srl
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 GE Healthcare
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 SWOT Analysis
  • 13.3.4 Hologic Inc.
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 Inbody Co. Ltd.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
  • 13.3.6 Omron Corporation
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
    • 13.3.6.4 SWOT Analysis
  • 13.3.7 RJL Systems Inc.
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
  • 13.3.8 Seca GmbH & Co. Kg.
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
  • 13.3.9 SELVAS Healthcare
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
  • 13.3.10 Tanita Corporation
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio